LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 41.17 | 770.25 | 5185 | 5010 | 1.0348 | 1.0255 | MN20160304_L02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 43.39 | 770.25 | 4812 | 5404 | 0.8904 | 0.9191 | MN20160304_L02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 43.39 | 770.25 | 5623 | 5404 | 1.0405 | 1.0284 | MN20160304_L02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 45.61 | 770.25 | 5206 | 5813 | 0.8956 | 0.9258 | MN20160304_L02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 45.61 | 770.25 | 6076 | 5813 | 1.0452 | 1.0306 | MN20160304_L02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 47.83 | 770.25 | 5598 | 6223 | 0.8995 | 0.9309 | MN20160304_L02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 47.83 | 770.25 | 6520 | 6223 | 1.0476 | 1.0311 | MN20160304_L02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 50.05 | 770.25 | 6058 | 6629 | 0.9138 | 0.9428 | MN20160304_L02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 50.05 | 770.25 | 7009 | 6629 | 1.0572 | 1.0362 | MN20160304_L02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 52.27 | 770.25 | 6444 | 7058 | 0.9129 | 0.9438 | MN20160304_L02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 52.27 | 770.25 | 7386 | 7058 | 1.0463 | 1.0285 | MN20160304_L02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 54.49 | 770.25 | 6750 | 7555 | 0.8934 | 0.9327 | MN20160304_L02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 54.49 | 770.25 | 7805 | 7555 | 1.0330 | 1.0198 | MN20160304_L02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 56.71 | 770.25 | 7228 | 8001 | 0.9033 | 0.9407 | MN20160304_L02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 56.71 | 770.25 | 8207 | 8001 | 1.0257 | 1.0151 | MN20160304_L02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 58.94 | 770.25 | 7659 | 8444 | 0.9070 | 0.9443 | MN20160304_L02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 58.94 | 770.25 | 8662 | 8444 | 1.0258 | 1.0148 | MN20160304_L02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 61.16 | 770.25 | 8078 | 8892 | 0.9085 | 0.9463 | MN20160304_L02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 61.16 | 770.25 | 9067 | 8892 | 1.0197 | 1.0111 | MN20160304_L02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 63.39 | 770.25 | 8470 | 9326 | 0.9082 | 0.9472 | MN20160304_L02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 63.39 | 770.25 | 9446 | 9326 | 1.0129 | 1.0071 | MN20160304_L02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 65.61 | 770.25 | 8777 | 9736 | 0.9015 | 0.9441 | MN20160304_L02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 65.61 | 770.25 | 9916 | 9736 | 1.0185 | 1.0100 | MN20160304_L02 | I17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 67.83 | 770.25 | 9116 | 10078 | 0.9045 | 0.9466 | MN20160304_L02 | E19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 67.83 | 770.25 | 10218 | 10078 | 1.0139 | 1.0074 | MN20160304_L02 | I17 |